4.5 Review

Phase angle in assessment and monitoring treatment of individuals with respiratory disease

Journal

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
Volume 24, Issue 3, Pages 491-502

Publisher

SPRINGER
DOI: 10.1007/s11154-023-09786-5

Keywords

Bioelectrical impedance analysis; Phase angle; Chronic obstructive pulmonary disease; Idiopathic pulmonary fibrosis

Ask authors/readers for more resources

Phase angle (PhA) is a raw variable measured with bioelectrical impedance analysis (BIA) and is used to assess malnutrition in various diseases, including chronic obstructive pulmonary disease (COPD). Reduced PhA is associated with older age, hypoxia, hypercapnia, reduced cell mass, muscle depletion, and worsening gas exchange in COPD patients. PhA degrees have significance in estimating muscle strength and respiratory muscles function, and are related to all-cause mortality in COPD patients.
Phase angle (PhA) represents a raw variable measured with bioelectrical impedance analysis (BIA) that is used to assess malnutrition in many diseases, including respiratory diseases, mainly chronic obstructive pulmonary disease (COPD). COPD patients with reduced PhA are older, more hypoxic and hypercapnic; patients with more severe COPD have reduced cell mass, evident skeletal muscle depletion, and worsening gas exchange. Malnourished patients with stable COPD in long-term oxygen therapy (LTOT) have more intense dyspnea at rest, greater weight loss over the past 12 months, and more exacerbations per year. Multiple regression analysis highlighted the significance of PhA degrees in the estimation of muscle strength: hand grip strength (HGS) and in that of respiratory muscles: maximal inspiratory pressure / max. expiratory pressure ratio (MIP/MEP). Furthermore, the relationship between PhA degrees and all-cause mortality in COPD patients was confirmed with the Cox regression model, Kaplan-Meier test, and log-rank tests. The role of malnutrition in idiopathic pulmonary fibrosis (IPF) is confirmed by the PhA degrees measurements which, regardless of body weight, is associated with the reduction in muscle mass of these patients, reduces their strength and exercise capacity, and greatly influences the prognosis. In conclusion PhA is a novel biomarker of morbidity and mortality in patients with severe respiratory diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available